Direct detection of viral RNA in human or other animal cells by RNA in situ hybridization (ISH) technology is a powerful tool to establish the etiology and pathogenesis of viral disease. Nucleic ...

MINNEAPOLIS, April 8, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), part of Bio-Techne's Spatial Biology Division, has surpassed ...

The RNAscope in situ hybridization (ISH) technology is a powerful method for detecting gene expression with spatial and morphological tissue context. In this webinar, we will focus on an Integrated Co ...

(RTTNews) - Bio-Techne Corp. (TECH) said that its RNAscope technology aids in the retrospective tissue diagnosis of covid-19 in cases with no previous testing for SARS-CoV-2. The company said it is ...

Advanced Cell Diagnostics (ACD), a Bio-Techne (TECH) spatial biology brand, achieves technical breakthrough enabling protease-free, same-slide detection of protein and RNA biomarkers using ...

MINNEAPOLIS, Sept. 22, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD)-branded RNAscope™ technology with release of the ...

Reveal Biosciences, LLC, a leading preclinical services laboratory for advanced tissue technologies, is pleased to announce the availability of Advanced Cell Diagnostics' (ACD) RNAscope® in situ ...

Advanced Cell Diagnostics (ACD) recently announced two major milestones for its RNAscope® RNA in situ hybridization technology. In just three years, over 100 peer-reviewed papers featuring the ...

Leica Biosystems, a Danaher company and a global leader in anatomic pathology solutions, and Bio-Techne (NASDAQ: TECH), a global provider of life science tools, reagents and diagnostic products, ...

Bio-Techne Corporation today announced that Advanced Cell Diagnostics (ACD), part of Bio-Techne's Spatial Biology Division, has surpassed 10,000 peer-reviewed publications referencing the use and ...